Correlation Between Vir Biotechnology and Bausch Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vir Biotechnology and Bausch Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vir Biotechnology and Bausch Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vir Biotechnology and Bausch Health Companies, you can compare the effects of market volatilities on Vir Biotechnology and Bausch Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vir Biotechnology with a short position of Bausch Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vir Biotechnology and Bausch Health.

Diversification Opportunities for Vir Biotechnology and Bausch Health

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vir and Bausch is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Vir Biotechnology and Bausch Health Companies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bausch Health Companies and Vir Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vir Biotechnology are associated (or correlated) with Bausch Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bausch Health Companies has no effect on the direction of Vir Biotechnology i.e., Vir Biotechnology and Bausch Health go up and down completely randomly.

Pair Corralation between Vir Biotechnology and Bausch Health

Considering the 90-day investment horizon Vir Biotechnology is expected to generate 1.26 times more return on investment than Bausch Health. However, Vir Biotechnology is 1.26 times more volatile than Bausch Health Companies. It trades about 0.1 of its potential returns per unit of risk. Bausch Health Companies is currently generating about -0.01 per unit of risk. If you would invest  523.00  in Vir Biotechnology on September 11, 2025 and sell it today you would earn a total of  132.00  from holding Vir Biotechnology or generate 25.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vir Biotechnology  vs.  Bausch Health Companies

 Performance 
       Timeline  
Vir Biotechnology 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vir Biotechnology are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak forward indicators, Vir Biotechnology reported solid returns over the last few months and may actually be approaching a breakup point.
Bausch Health Companies 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Bausch Health Companies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, Bausch Health is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Vir Biotechnology and Bausch Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vir Biotechnology and Bausch Health

The main advantage of trading using opposite Vir Biotechnology and Bausch Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vir Biotechnology position performs unexpectedly, Bausch Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will offset losses from the drop in Bausch Health's long position.
The idea behind Vir Biotechnology and Bausch Health Companies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories